David Hovland
General Counsel bei ELEDON PHARMACEUTICALS, INC.
Aktive Positionen von David Hovland
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELEDON PHARMACEUTICALS, INC. | General Counsel | 19.04.2021 | - |
Karriereverlauf von David Hovland
Ehemalige bekannte Positionen von David Hovland
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UROVANT SCIENCES LTD. | General Counsel | 01.04.2018 | 01.04.2021 |
ALLERGAN PLC | General Counsel | 01.01.2015 | 01.01.2018 |
Corporate Officer/Principal | 01.01.2010 | 01.01.2015 | |
AMGEN INC. | General Counsel | 01.01.2006 | 01.01.2010 |
ALLERGAN PLC | Corporate Officer/Principal | 01.01.1999 | 01.01.2002 |
Ausbildung von David Hovland
University of California, Los Angeles | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 2 |
Irland | 2 |
Operativ
General Counsel | 4 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMGEN INC. | Health Technology |
ELEDON PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- David Hovland
- Erfahrung